TrialThe Journal of clinical investigation2023

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.

David H McDermott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.